Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Trial Using Novel Markers to Predict Malignancy in Elevated-Risk Women

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborators:
The Marsha Rivkin Center for Ovarian Cancer Research
Canary Foundation
Swedish Medical Center
City of Hope Medical Center
Cedars-Sinai Medical Center
Stanford University
Fox Chase Cancer Center
Information provided by (Responsible Party):
Fred Hutchinson Cancer Research Center
ClinicalTrials.gov Identifier:
NCT01121640
First received: May 10, 2010
Last updated: September 19, 2016
Last verified: September 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: June 2017
  Primary Completion Date: June 2015 (Final data collection date for primary outcome measure)